RICCIARDI, GIUSEPPINA ROSARIA
 Distribuzione geografica
Continente #
EU - Europa 1.746
NA - Nord America 1.532
AS - Asia 682
SA - Sud America 213
Continente sconosciuto - Info sul continente non disponibili 36
AF - Africa 33
OC - Oceania 1
Totale 4.243
Nazione #
US - Stati Uniti d'America 1.491
RU - Federazione Russa 962
SG - Singapore 258
CN - Cina 224
BR - Brasile 178
IE - Irlanda 175
SE - Svezia 174
IT - Italia 124
HK - Hong Kong 69
FR - Francia 58
DE - Germania 50
GB - Regno Unito 44
FI - Finlandia 39
VN - Vietnam 35
IN - India 34
PL - Polonia 34
UA - Ucraina 22
AT - Austria 20
BE - Belgio 19
CA - Canada 15
AR - Argentina 12
BD - Bangladesh 10
CO - Colombia 10
ZA - Sudafrica 10
ID - Indonesia 9
MX - Messico 8
TR - Turchia 8
MA - Marocco 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
SC - Seychelles 5
EC - Ecuador 4
ES - Italia 4
NL - Olanda 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
IL - Israele 3
JM - Giamaica 3
JP - Giappone 3
KE - Kenya 3
LT - Lituania 3
PE - Perù 3
PR - Porto Rico 3
UZ - Uzbekistan 3
BO - Bolivia 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
EG - Egitto 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
LV - Lettonia 2
PH - Filippine 2
PS - Palestinian Territory 2
PY - Paraguay 2
SV - El Salvador 2
VE - Venezuela 2
AI - Anguilla 1
AO - Angola 1
AU - Australia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
IM - Isola di Man 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
ML - Mali 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
RO - Romania 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 4.209
Città #
Moscow 270
Ashburn 251
Dublin 174
Chandler 159
Singapore 146
Dallas 145
San Jose 91
Nyköping 86
Beijing 85
Hong Kong 69
Jacksonville 54
Ann Arbor 52
The Dalles 51
Los Angeles 40
New York 37
Messina 33
Warsaw 32
Council Bluffs 31
Princeton 25
Medford 24
Cambridge 23
Lauterbourg 21
Munich 21
Brussels 19
Des Moines 19
Dearborn 18
Pune 18
Vienna 18
Buffalo 14
Tianjin 14
Boardman 13
Woodbridge 13
Phoenix 12
São Paulo 12
Milan 10
Hanoi 9
Ho Chi Minh City 9
Jinan 9
Santa Clara 9
Lancaster 8
Nanjing 8
San Mateo 8
Manchester 7
Turku 7
Chennai 6
Helsinki 6
Redondo Beach 6
Wilmington 6
Denver 5
Dong Ket 5
Frankfurt am Main 5
Johannesburg 5
Orem 5
Poplar 5
Shanghai 5
Stockholm 5
Ankara 4
Brooklyn 4
Giardini-Naxos 4
Hangzhou 4
Hebei 4
Houston 4
Jakarta 4
Leawood 4
Montreal 4
Orta di Atella 4
Shenyang 4
Toronto 4
Bogotá 3
Bremen 3
Campinas 3
Casablanca 3
Chicago 3
Duque de Caxias 3
Fuzhou 3
Goiânia 3
Guangzhou 3
Ipatinga 3
Istanbul 3
Jiaxing 3
Joinville 3
Las Vegas 3
London 3
Medellín 3
Mexico City 3
Montes Claros 3
Mumbai 3
Nairobi 3
Nanchang 3
Naples 3
Ningbo 3
Olomouc 3
Ribeirão Preto 3
Rio de Janeiro 3
Rome 3
Roubaix 3
Shenzhen 3
São Bernardo do Campo 3
Tashkent 3
Trepuzzi 3
Totale 2.382
Nome #
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 252
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients 242
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 227
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 223
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis. 205
Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate synthase (TS) promoter and methlylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants expression on patients’ outcome and correlation with p53 codon 72 mutations. 198
Preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes for the assessment of metastasis risk in breast cancer (BC). 188
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. 187
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications. 181
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. 179
Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study. 166
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. 164
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 156
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy 155
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience. 145
Uncommon breast metastatic site and eribulin responsiveness in a heavily pretreated patient 144
Observational study to evaluate the pattern of trastuzumab (T) use and survival outcomes in HER2-positive (HER2+) early breast cancer (EBC): Regional Southern Italy experience. 132
Multicenter study in women with infracentimetric HER2 positive breast cancer: The Regional Sicilian experience. 130
Infra-centimetric HER2 positive Breast Cancer: The Southern Italy Experience. 128
Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience. 127
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series. 124
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 114
Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives. 114
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. 103
null 72
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. 69
null 52
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes 44
null 22
Totale 4.243
Categoria #
all - tutte 13.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022155 0 0 0 0 3 4 10 6 3 47 23 59
2022/2023551 39 61 21 45 47 63 9 33 218 1 11 3
2023/2024203 7 21 11 12 9 70 57 2 2 3 2 7
2024/2025539 5 6 9 30 20 33 8 103 143 38 54 90
2025/20261.987 107 123 138 113 152 434 259 286 259 75 19 22
2026/2027262 19 56 76 96 15 0 0 0 0 0 0 0
Totale 4.243